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Abstract 
 
  
INDICES OF AIRWAY FUNCTION IN IN-SEASON COLLEGIATE SWIMMERS 
OVER EIGHT WEEKS  
 
 
Hannah Snyder 
B.S., Towson University 
M.S., Appalachian State University 
 
 
Chairperson:  Jonathon Stickford, Ph. D 
 
 
The repeated exposure to disinfectant by-products in swimming pool 
environments may worsen pulmonary function and contribute to symptoms of exercise 
induced bronchoconstriction (EIB) in swimmers. The purpose of this study was to 
comprehensively examine whether spirometric indicators of pulmonary function change 
over an indoor swim season in competitive collegiate swimmers and to perform a pilot 
investigation on the efficacy of fish-oil supplementation in swimmers with EIB over the 
course of 8 weeks. Competitive swimmers (n=13, 18-25 years of age) were recruited for 
participation in the study. Swimmers underwent pulmonary function and submaximal 
exercise testing (if part of the EIB portion of the study) before and after an eight-week 
period. Additionally, pulmonary function was assessed at 3 and 6 weeks. Data were 
analyzed using a one-way ANOVA and t-test in the SPSS data software. Researchers 
observed no significant changes in pulmonary function or EIB over the course of an 8-
week swim season.   It is important to understand the physiological impact inhalation of 
chemical by-products may have on swimmers throughout their lifetime. Looking at this 
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impact may help to ultimately improve the swimmers performance over the course of 
his/her swimming career. A better understanding of treatments for asthma and EIB 
symptoms is needed to help abate long term respiratory limitations that may occur due to 
pool environment exposure. It is also important to further exam pool quality standards to 
provide a safe and healthy pool environment for these athletes.  
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Foreword 
 This thesis will form the basis of a manuscript to be submitted to the International 
Journal of Exercise Science; it has been formatted according to the style guide for that 
journal.  
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Chapter 1 
INTRODUCTION 
It is widely recognized that competitive swimmers spend a large amount of time 
training to increase their performance. Researchers have found swimmers have greater 
measures of pulmonary function when compared to control groups of the same age, 
weight, and stature as other athletes (12, 15, 57). When compared to athletes engaged in 
other activities (i.e., running, basketball, canoeing, and rowing) and sedentary controls, 
swimmers had superior forced expiratory volume (FEV1), an indicator of airway 
function, independent of stature and age (12, 15). Thus, from a superficial perspective, it 
appears that swimmers exhibit greater pulmonary and airway function compared with 
other athletes. 
Public swimming pools are required by law to use disinfectants in order to kill 
and prevent the spread of bacteria. Pool water disinfectants include chlorine (gas, 
calcium/sodium hypochlorite, or chlorine dioxide), bromine 
(bromochlorodimethylhydantoin), ozone, and/or ultraviolet radiation, with chlorine being 
the most common (18, (Ondolo, 2009 #32, 49)). Yet, during swim exercise, chemical 
disinfectants react with biological materials (i.e. sweat, skin oils, urine, etc.) introduced to 
the pool environment. As a result of this reaction, disinfectant by-products are produced, 
whereby the greatest concentration accumulates at the water’s surface. Therefore, the air 
that swimmers breathe during exercise, regardless of stroke style/technique, contains the 
greatest proportion of toxic chemicals (i.e., chemical disinfectant by-products) known to 
impair respiratory health (18, 29, 49). The amount of time and ventilatory volume during 
exercise are determinants of exposure to disinfectant by-products.  Individuals who swim 
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for long periods of time and at moderate to vigorous activity levels, such as competitive 
swimmers, are exposed to more by-products than those who do not.  On a daily basis, a 
competitive swimmer may be exposed to disinfectant by-products for two to five hours.  
The effect of the amount of swimming pool environment exposure on pulmonary 
function has not been thoroughly investigated.  Studies have been conducted examining 
the effects of swimming pool environments on respiratory health of pool attendants and 
leisure swimmers, however, research using competitive swimmers is lacking. 
Though swimmers may have larger respiratory muscle mass and generally greater 
pulmonary function measures than the general population, the pool environment may still 
have an effect on swimmers’ lung function. Swimmers have shown increased sputum 
eosinophilia and higher exhaled breath temperatures after training (13).  Rhino-sinusual 
disorders, external otitis, dermatitis, conjunctivitis, and upper respiratory tract infections 
are common disorders of competitive swimmers (49).  Ferrari et al. found participants 
who visited indoor pools more frequently developed new onset asthma at a significantly 
higher rate than those who did not (17, 49).  Nordberg et al. (46) also found a significant 
decrease in FEV1 after two hours of exposure to swimming pool environments. 
Traditionally, swimming exercise is regarded as one of the best modes of exercise 
for individuals with exercise-induced bronchoconstriction (EIB) (39). EIB is a transient 
narrowing of the bronchial airways during (6) or after (37) vigorous exercise, which 
results in airflow limitation.  Yet, despite this “favorable” environment, the prevalence of 
EIB among swimmers is greater than in athletes of all summer sports and most winter 
sports (39). EIB is estimated to affect approximately 90% of asthmatic individuals and 
35-40% of those suffering from allergic rhinitis (30).  Additionally, a high prevalence of 
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airway hyperresponsivness has been reported in many elite level athletes (36 to 79%), 
including cross country skiers, long distance runners, figure skaters, and swimmers (21).  
Thus, this observation leads one to wonder, if swimming is truly the best (e.g., most 
recommended) mode of exercise for individuals with asthma and EIB, why is the 
prevalence of EIB so great among competitive swimmers (21)? 
While the underlying mechanism of EIB is not completely known, it likely 
involves loss of heat and water from the conducting airways during the ventilatory 
process of conditioning the inspired air. In addition to common medical treatment (e.g., 
beta agonist), supplementation with dietary nutrients/compounds (i.e., ascorbic acid, 
vitamin E, omega-3 fatty acids, and zinc) has been shown to effectively abate the 1) 
reduction in lung function and 2) the inflammatory response typically observed in 
individuals with EIB (7). Little research has been done on the effects of indoor swimming 
pool environments on swimmer lung functions over the course of a swimming season.   
There is a need for future research to study the effects of swimming pool environments 
on pulmonary function of swimmers over the course of a season to understand if 
antioxidant supplements help to decrease change in pulmonary function.   
Statement of the Problem 
The purpose of this study was twofold: 1) to comprehensively examine whether or 
not spirometric indicators of pulmonary function change over an 8-week portion of the 
indoor swim season in competitive collegiate swimmers and 2) to perform a pilot 
investigation on the efficacy of fish-oil supplementation in swimmers with EIB over the 
course of 8 weeks. 
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Hypotheses 
The following hypotheses will be tested: 
1. Pulmonary function, characterized by FEV1, will decrease from week 0 to week 8 
in competitive swimmers. 
2. The change in pulmonary function, characterized by a change in FEV1, in 
competitive swimmers with EIB in response to an exercise challenge will be 
reduced following 8 weeks of fish oil supplementation compared with a control. 
3. Markers of airway bronchoconstriction, characterized by the presence of cysteinyl 
leukotrienes in the urine in response to an exercise challenge, in competitive 
swimmers with EIB will be reduced at the conclusion of an indoor swim season 
following fish oil supplementation compared with a control. 
Delimitations 
The study will be delimited by the following factors: 
1. The participants selected will be male or female competitive swimmers, aged 
18 to 25 years. 
2. Swimmers who have injuries or illnesses that exclude them from practice or 
meets for more than one week will not participate in the study. 
3. Diet will be monitored at Weeks 0 and 8 using a Food Frequency 
Questionnaire (FFQ) to ensure the potential change in pulmonary function is a 
result of the treatment only.  
4. Bronchodilator usage will be monitored using a Medication Log to ensure 
potential change in pulmonary function is result of treatment only. 
5.  
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Limitations 
The following limitations will be considered when interpreting the results of the research: 
 
1. The effort displayed by the swimmer will be assumed to be the best ability of the 
participant.  
2. The supplements given to participants are assumed to be pure.  
3. All of the swimmers will reside in the same geographical area.  
4.  Allergens in the air due to location potentially may have an effect on airway 
hyperresponsivenes that cannot be controlled. 
5. The chemical by-product concentrations at the water’s surface will not be 
assessed.   
6. The pool environment for all participants will be the same. 
7. The yardage and pool exposure for all participants will be the same. 
Definition of Terms 
For the purpose of the study, the following definitions will be utilized: 
Airway Hyperresponsiveness (AHR): A characteristic of asthma and EIB which consists 
of an increased sensitivity of the airways to constrictor agonists (47). 
Eucapnic Voluntary Hyperventilation (EVH) Test: A provocative indirect stimulus test 
used to diagnose exercise-induced asthma or exercise-induced bronchospasm (1). 
Exercise Induced Asthma (EIA): An exacerbation of asthma symptoms during exercise 
in individuals diagnosed with asthma (5). 
Exercise Induced Bronchoconstriction (EIB): A participant who shows evidence of 
asthma symptoms during or after exercise (26). 
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Forced Expiratory Volume: A measurement of how much air a participant can exhale 
during a forced breath (44). 
Forced Expiratory Volume in 1 second (FEV1): The maximum volume of air that can be 
forced out in one second started from a level of total lung capacity, an important measure 
of pulmonary function (20). 
Forced Vital Capacity (FVC): The volume of air expelled by a forced maximal 
expiration to residual volume after a full inspiration (20). 
Forced Expiratory Flow 25-75 % (FEF25-75 %): The average expiratory flow over the 
middle half of the FVC (20). 
Pulmonary Function Test (PFT): A gauge of how the lungs are expanding and 
contracting and measures the efficiency of the exchange of oxygen and carbon dioxide 
between the blood and the air within the lungs (44). 
Leukotriene C4/D4/E4 (LTC4, LTD4, LTE4), Cysteinyl Leukotrienes: Category of 
leukotrienes released by mast cells and eosinophils which have been shown to 
accompany exercise bronchial reactivity by increased concentrations in urine (50). 
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Chapter 2 
REVIEW OF LITERATURE 
The literature related to the effect of chlorinated, indoor swimming pools on 
swimmers and the effects of fish oil supplementation on respiratory system health are 
presented in this chapter.  The following review of literature will discuss (a) pulmonary 
function in swimmers,  (b) respiratory health in swimmers and pool attendance, (c) the 
swimming pool environment, (d) EIB, and (e) the potential treatments for EIB.  
Pulmonary Function in Competitive Swimmers 
Researchers have found swimmers have greater measures of pulmonary function 
when compared to control groups of the same age, weight, and stature and other athletes 
(12, 15, 57). In a study performed on children and preadolescents with at least 3 years of 
swimming training, results indicated children who train to swim competitively have 
cardiorespiratory capacities which are greater than one would expect to see in untrained 
youth of similar ages (15, 57).  Vaccaro et al. found measures of total lung capacity 
(TLC), forced vital capacity (FVC), and forced expiratory capacity in one second (FEV1) 
in child and preadolescent swimmers were approximately 10-16% above normal after 3 
years of training (41, 57). When compared to land based activities (runners, basketball, 
canoeing, and rowing) and sedentary controls, swimmers had superior FEV1 independent 
of stature and age (12, 15). 
Respiratory Health in Swimmers and Pool Attendance 
In swimming, individuals experience increased load of the water pressure against 
the chest wall and elevated airway resistance as the result of immersion.  Researchers 
found that the elevated pressure could comprise a conditioning stimulus to influence a 
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positive impact on swimmers lung volumes (15, 33). Training factors, such as breath 
holding and rhythmic breathing, did not influence the lung volumes of swimmers but did 
have a positive impact on lung ventilatory functions (33).  Though swimmers may have 
larger respiratory muscle mass and generally greater pulmonary function measures than 
the general population, respiratory limitations seem to still have an effect on swimmers’ 
lung function.   
Swimmers lung function becomes limited over time due to the inflammation and 
edema of the mucous membranes of the lungs (29).  It is believed swimmers exposure to 
the chlorine by-products at the surface of the water causes this effect on their lung 
function. During a two-hour period of swimming, swimmers may be exposed to amounts 
of chlorine gas exceeding the United States recommended exposure limit for an eight-
hour chemical factory worker (21). 
Swimmers have shown increased sputum eosinophilia and higher exhaled breath 
temperatures after training (13).  An analysis of induced sputum in elite swimmers who 
did not have asthma showed increased inflammatory cells compared to healthy non-
swimmers (17). Two factors that contribute to these types of mediators of 
bronchoconstriction in competitive swimmers are hyperventilation associated with 
endurance training and chronic exposure to chlorine derivatives (9, 22).  Rhino-sinusual 
disorders, external otitis, dermatitis, conjunctivitis, and upper respiratory tract infections 
are common disorders of competitive swimmers (49). In a study conducted on 20 elite 
swimmers, 83% reported respiratory symptoms and 65% had at least one positive 
bronchial hyperresponsive provocation test (55).  
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Prevalence of asthma in swimmers increases by 45% with a mean nine years of 
training  (13).  Ferrari found participants who visited indoor pools more frequently 
developed new onset asthma at a significantly higher rate than those who did not (17).  
Nordberg et al. found a statistically significant relationship between the number of hours 
spent in an indoor swimming pool environment and the age of acute asthma symptoms 
(i.e. dyspnea, cough, nose, throat, and eye irritation) (46). They also found a significant 
decrease in FEV1 after two hours of exposure to swimming pool environments (46).   
Increased attendance at swimming pools is correlated with higher input of organic 
and minerals pollutants introduced by swimmers in the swimming pool water (18).  In a 
study conducted by Florentin et al. elite swimmers individually secreted around 20-80 
mL of urine and produce 0.1-1.0 L of sweat in 2 hours (18).  The mineral nitrogen 
compounds found in the urine react with free chlorine to form chloramines.  The presence 
of chloramines in the air of swimming pools was associated with an increased prevalence 
of allergic symptoms (i.e. Rhino-sinusal disorders, external otitis, dermatitis, 
conjunctivitis, and upper respiratory tract infections) and asthma in elite swimmers 
training in indoor swimming pool environments (18, 45, 49).  An increase in pathological 
conditions when swimming in indoor pools for more than 30 hours/week was also found 
(49).   
Daily or intermediate exposure to “normal” indoor pool atmospheres have been 
shown to be as pungent and irritating for the eyes and upper airways as some industrial 
environments (45).  Concentrations of chloramines are generally higher in pools with 
recreational activities, especially slides and whirl pools (29).  The first complaints of 
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irritation were registered at around 0.5 mg m-3 of chloramines and all participants 
complained at concentrations of 0.7 mg m-3 (29).   
A statistically significant relationship was found between the number of hours 
spent in swimming pool environment and the acute symptoms (i.e. dyspnea, cough, nose 
irritation, throat irritation, eye irritation) (46).  A significant decrease in pool attendee 
FEV1 were found after 2 hours of exposure in a study conducted by Nordberg et al. (46). 
Considerable lung function changes and patterns were found in swimming pool 
instructors (29). 
The Swimming Pool Environment 
Chlorine is a chemical element and is the second lightest of the halogens.  
Chlorine is a toxic gas that attacks the respiratory system, eyes, and skin (52). Because it 
is denser than air, it tends to accumulate at the bottom of poorly ventilated spaces. 
Chlorine gas is a strong oxidizer, which may react with flammable materials (52).  
Chlorine is the most frequently used disinfectant in swimming pools (29, 45). 
Disinfection by-products, such as chloramines, are created from organic matter (i.e. 
sweat, urine, and skin).  The most volatile and easily released of these chloramines are 
trichloramines (29) Trichloramines are the most likely contaminant suspected to cause 
irritated respiratory symptoms among swimmers and workers (29). The recommended 
level of trichloramines is <0.5 mg-m-3 (41). Most pools averaged 0.67 mg-m-3 (29).  
Production of chloramines depends on degree of water chlorination, contamination of 
water by nitrogen compounds, water temperature, water circulation, and ventilation.  
Researchers have found a significant association between chloramine levels and the 
number of swimmers, free chlorine concentration in pool, and ceiling height (29).  An 
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increase of 50 bathers was associated with a .40 mg-m-3 increase in trichloramine level 
(29) and ventilation has been known to lead to lower air contamination (34).   
Visiting chlorinated pools strongly relates to prevalence of asthma and positive 
exercise-induced bronchoconstriction and long-term exposure had a significant 
association with upper respiratory symptoms (29).  Researchers have found that levels of 
chloramines were somewhat lower in leisure pools compared to competition pools.  
Currently, there are no regulations that exist for air quality in indoor swimming pools 
(29). 
Exercise-Induced Bronchoconstriction 
EIB is “a transient narrowing of the airways that occurs during or after exercise” 
(26). Upon hyperventilation during high intensity exercise, mouth breathing promotes the 
inhalation of cooler, drier air compared with water content of air and tissue existent in the 
lung (28). Currently, there are two dominating theories about the underlying mechanism 
responsible for EIB. The first theory states vasodilation of the bronchiolar blood vessels 
results after exercise as heat passes down its thermal gradient to rewarm the airway.  This 
results in vascular hyperemia and pulmonary edema, which results in airflow limitation 
(40). The second theory states water is lost from the bronchial epithelium as it humidifies 
the drier inhaled air. The subsequent water loss increases tissue osmolality, which 
activates the release of histamine and pro-inflammatory mediators causing 
bronchoconstriction (3). Although the actual mechanism is probably some combination 
of the two, the role and release of inflammatory mediators has been well documented 
(31). Tumor necrosis factor-α (TNF-α) and interleukin-1 (IL-1) are released in response 
to airway trauma, which initiates the inflammatory response. Arachidonic metabolites, 
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including cysteinyl 4-series leukotrienes (LTC4, LTD4, LTE4) and prostaglandin (PG) D2 
are potent mediators causing bronchoconstriction (48) (Figure 1).  
The bronchoconstrictive effect results in lung function deterioration characterized 
by at least a 10% decrease in post-exercise forced expiratory volume in one second 
(FEV1) compared to resting baseline values, with the greatest decreases occurring 5-10 
minutes after the cessation of exercise  (16). Mean mid-expiratory flow (FEF25-75 %) 
decreases of 15-25 % have also been accepted as a positive diagnosis of EIB (53). 
Breathlessness, cough, and increased mucus production are reported frequently in athletes 
with EIB (31).        
Prevalence of EIB in Swimmers 
 Mediators of bronchoconstriction seems to affect swimmers, ice hockey players, 
and cross country skiers more than any other type of athlete (22).  “Olympic level 
swimmers are more likely to have asthma, airway hyperresponsiveness, positive skin 
prick tests, and allergic rhinoconjunctivitis than any other group of athletes” (22).  In a 
Figure 1. Leukotriene synthesis and actions (19) 
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study done by Haahtela et al., asthma in swimmers was increased nearly six-fold and the 
risk of asthma is 96 fold compared to the controlled participants (21).  
In a study conducted by Holmer , trained swimmers, cyclists, and runners have 
approximately the same V̇O2max (27).  The difference between the three groups was 
maximum ventilation.  Swimmers have a lower ventilation rate for the same VȮ2max 
when compared to trained runners and cyclists (Figure 2).  
Figure 2. Pulmonary ventilation, maximum oxygen uptake, and heart rate during maximal running, 
cycling, and swimming (27). 
Why is it that, of these three types of athletes (swimmers, runners, and cyclists), 
swimmers are more likely to have EIB?  It is believed that the exposure to the chlorine 
by-products causes inflammation and edema of the mucous membranes of the lungs (29).  
During a two-hour period of swimming, swimmers may be exposed to amounts of 
chlorine gas exceeding the United States recommended exposure limit for an eight-hour 
chemical factory worker (21). 
Individuals who exercise in indoor swimming pools for five or more hours per 
week increase their risk of developing asthma or EIB by 5% yearly (17).  Competitive 
swimmers are at a higher risk of developing bronchial hyper-responsiveness than other 
summer athletes (17).  Nordberg found a statistically significant relationship between the 
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hours spent in a swimming pool environment and the age of acute symptoms (i.e. 
dyspnea, cough, nose irritation, throat irritation, and eye irritation) (46).  The researchers 
reported a significant decrease in FEV1 after two hours of exposure to indoor swimming 
pool environments.  
Haahtela found that athletes who train indoors report more exercise-induced 
respiratory symptoms than outdoor training (21).  This effect was also seen in athletes 
training outdoors at subzero temperatures.  A study conducted at the Olympic Games in 
Athens, Greece in 2004 suggests that environment and training, such as indoor pool 
environments and endurance training, contribute to the incidents of asthma in swimmers 
(22).  Competitive swimmers breathe the air floating just above the surface of the water 
encouraging them to inhale water droplets and chemicals (22).  The presence of 
chloramines in the air of swimming pools was associated with an increased prevalence of 
EIA and EIB in elite swimmers (18, 33, 41).  Due to the daily exposure of chloramines, 
swimmers’ lungs created an inflammatory response to heal damage; however, repair was 
delayed because of frequent exposure (13).   
Treatment Methods 
Treatment methods currently used to limit EIB exacerbations are bronchodilators. 
According to Liesker, the main purpose of a bronchodilator is “to decrease airflow 
limitation in the airways and, as a consequence, improve dyspnea and exercise tolerance 
(36).”  A bronchodilator consists of some form of beta agonist (51).  Stimulation of beta 
adrenergic receptors can result in vasodilation of blood vessels and tachycardia (37). In 
addition, it has been found chronic exposure to beta agonist drugs leads to reduced 
responsiveness and a decrease in the number of receptors to the agonist (61). 
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 In a study conducted by Wraight, the effects of tolerance increased as use of 
bronchodilator increased (61).  The results of the Wraight study demonstrated a decrease 
in response to bronchodilators acutely administered to patients who have continuous 
exposure to inhaled beta agonist (61).  The increasing tolerance to bronchodilators 
linearly correlated with bronchoconstriction (61).  In four studies conducted by Hancox, 
Wahedna, Vathenen, and Van Schayck, researchers found discontinuation of short acting 
beta agonists decreased FEV1 and increased bronchial responsiveness (23, (Wahedna I, 
1993 #66), (59), (58)). 
 Currently, bronchodilators are the main source of treating asthma and 
bronchoconstriction.  The problem to be faced with this method of treatment is the impact 
of tolerance to the beta agonists.  Antioxidant treatment may offer an alternative 
treatment to EIB that avoids the tolerance issue because antioxidant act directly on the 
inflammatory mediator pathways. 
Omega-3 Fatty Acids and EIB 
A fatty acid is a carboxylic acid with a long aliphatic chain, which is either 
saturated or unsaturated.  Fatty acids are usually derived 
from triglycerides or phospholipids. Fatty acids are important dietary sources of fuel for 
animals because, when metabolized, they yield large quantities of adenosine triphosphate 
(ATP). Fatty acids that are required by the human body but cannot be made in sufficient 
quantity from other substrates, and therefore must be obtained from food, are called 
essential fatty acids. Two essential fatty acids are omega-3 and omega-6 fatty acids.  
  The human body breaks down omega- fatty acids into useful and more important 
long-chain omega-3 fatty acids, EPA and DHA, which help with fetal development and 
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healthy aging (25). Consumption of omega-3 fatty acids from marine sources has also 
shown lowers markers of inflammation in the blood (35).  Fish oil has been shown to 
play a role in shaping and regulating inflammatory processes and responses (43).  The 
research may suggest that the omega-3 fatty acids might be important in determining the 
development and severity of inflammatory diseases (43). The anti-inflammatory actions 
of omega-3 fatty acids has led to the idea that supplementation of the diet of patients with 
inflammatory diseases may be of clinical benefit (43).  In a study conducted by Calder, 
“fish oil supplementation in healthy human participants demonstrated a decrease in 
chemotaxis of neutrophils and monocytes towards various chemo-attractants including 
LTB4 (10).” 
Since 1930, leukotrienes have been known to play an important role in 
immunology, specifically in anaphylaxis (8).  During the break down of arachidonic acid, 
leukotrienes are produced by the enzyme 5-lipoxygenase (5-LO) (8).  The 5-LO pathway 
products have been detected in body fluids (i.e. blood and urine) after experimentally 
induced bronchoconstriction and during spontaneous asthma attacks (28). Leukotrienes 
produce mast cells, eosinophils, basophils, macrophages, and monocytes, all of which 
have been linked to cases of EIB (8).  Although leukotrienes are rapidly cleared from the 
blood, concentrations of these inflammatory mediators have been found specifically in 
bronchoalveolar lavage fluids take from patients with asthma.  Research has shown that 
leukotriene levels will return to baseline after 3 to 7 hours post exercise (38). 
The most potent chemotactic compound is Leukotriene B4 (LTB4) (32).  LTB4 
plays a significant role in inflammatory and allergic reactions” (32).  In a study 
conducted by Kumar, the formation of LTB4 from LTA4 was measured by incubating 
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lung microsomes from normal and exercised rats (32).  Production of LTB4 in lung 
microsomes almost doubled after exhaustive exercise in the form of swimming (32).  The 
results of the Kumar study suggest LTB4 plays a role in the involvement of lung tissue 
damage during exercise-induced oxidative stress (32). 
Additional Dietary Strategies and EIB 
 Physical exertion generates oxidative stress in the respiratory system (26).   
Oxidant stress can initiate apoptosis (death of cells) which can be prevented by 
antioxidants.  (60) Sridhar found that antioxidant such as vitamin C, vitamin E, beta-
carotene, vitamin A, fatty acids and some minerals play a protective role against lung 
inflammation.  A high intake of antioxidants in the diet can reduce the risk of respiratory 
disorders and increase FEV and FVC (54).   Deficiencies in dietary antioxidants and fatty 
acids may contribute to the prevalence of asthma in the United States and other countries 
(54).  High intakes of fruits and vegetables could reduce the risk of lung cancer in 
participants by close to 78% over the course of 12 years (54).   
 The effects on the severity of upper and lower respiratory tract infections and the 
common cold show the importance of vitamin C on the respiratory system (26). Vitamin 
C supplementation significantly improved pulmonary function, decreased mediators of 
inflammation, and provided a protective effect against airway narrowing caused by 
exercise (7).  In a study performed by Hemila, vitamin C supplementation reduced the 
postexercise FEV decline by 48% (26). Vissers found vitamin C and E are able to protect 
against oxidative stress and provide specific protection against the apoptotic process (60).  
Tecklenburg found that adding an ascorbic acid supplement to participant’s diets 
significantly improved post-exercise FEV1 and reduced EIB (56).  They found an absence 
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of significant difference in FEV1 between any of their treatment protocols, which 
suggests that the differences in treatments were due to changes in diet (56).  The 
maximum fall in FEV1 was halved on the ascorbic acid supplementation diet.   
 Like vitamin C and E, zinc plays a protective role in the lung and prevents 
pulmonary epithelial damage (7).  Biltagi found zinc decreased total sputum white blood 
cell count as well as other mediators of inflammation (7).  Zinc blocked the binding of 
white blood cells to endothelial cells and inhibited the release of mediators from mast 
cells, basophils, and eosinophils.  Biltagi states “zinc greatly reduces airway hyper-
responsiveness and inflammation (7).”  
 Omega-3 fatty acids primarily found in fish oil are essential to the human diet.  
Mickleborough found dietary fish oil supplements have a protective effect in suppressing 
EIB in elite athletes (42).  Omega-3 fatty acids improve lung functions, decrease the 
severity of bronchial asthma, and may make asthma easier to control (7).  Fish oil reduces 
the generation of proinflammatories and the production of cytokines from inflammatory 
cells.  Mickleborough and Rundell found that after three weeks of fish oil 
supplementation, the severity of EIB was reduced and significantly suppressed several 
proinflammatory mediators in elite athletes who demonstrated symptoms of EIB (53).  
Athletes who had EIB and were taking the fish oil supplement reduced the fall of FEV by 
80% 15 minutes post-exercise and the use of bronchodilators (i.e. inhalers) by 20%.  
Mickleborough found that a diet high in omega fatty acids suppressed urinary 
inflammatory mediator (9α and 11β-PGF) concentrations after exercise in elite athletes 
with EIB (42). 
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Summary of Findings 
 Though researchers have found swimmers to have larger VC, FVC, and FEV1 
than normal healthy individuals, the presence of chloramines in the air of swimming 
pools was associated with changes in pulmonary function in elite swimmers (18, 33, 41).  
The changes in pulmonary function include increased allergic symptoms and asthma (18, 
45, 49).  No research has been conducted serially examining pulmonary function of 
competitive swimmers over 8 weeks during the competitive indoor season.  Thus, there is 
a need for future research to study the effects of swimming pool environments on 
pulmonary function of swimmers over the course of a season.  EIB is especially prevalent 
in swimmers and potentially affects exercise performance (21).  Future research is needed 
specifically in order to gain an understanding of how better pulmonary function can allow 
swimmers to perform at an optimal level. 
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Chapter 3 
METHODS 
The research study was designed to investigate pulmonary function over the 
course of 8 weeks during an indoor season in competitive swimmers. Additionally, a pilot 
investigation was conducted to assess the physiologic effects of a polyunsaturated fatty 
acid, specifically an omega-3 fatty acid, on pulmonary function in swimmers with EIB.   
Participants 
Approval from the Institutional Review Board was provided prior to initiation of 
the project. Participants consisted of 13 competitive swimmers (12 female) ages 18-25 
years.  Data was collected during the months of September to December. Prior to the 
study, an e-mail was sent to competitive collegiate swimmers within the region asking for 
participation.  Informed consent was obtained prior to enrolling in the study.  All 
participants were medically cleared to participate in the study and swim training by the 
college medical staff.  Participants were excluded from participation if they had any 
injury or significant illness preventing them from practicing or competing during the 
swim season.   
Study design and protocols 
Following the consent process, all swimmers completed pulmonary function 
testing at study entry. Further, questionnaires were administered asking whether or not 
participants exhibited symptoms of or had previously be informed that they had EIB or 
exercise-induced asthma (EIA) (4, 16). If the participants answered positively, an 
exercise challenge test was used to confirm the presence of EIB, which was indicated by 
a more than 10% decrease in FEV1 following the exercise challenge compared with 
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before. Participants with EIB were administered a log sheet to record their use of all 
medications throughout the course of the study. Upon entry into and completion of the 
study, participants with EIB completed a food frequency questionnaire (FFQ) to monitor 
dietary habits.  Subsequently, participants with EIB were provided with a fish oil 
supplement to consume daily over the following 8 weeks. After the initial visit, all 
participants performed pulmonary function testing at weeks 3, 6 and 8. The participants 
with EIB also completed another exercise challenge test at week 8 in order to examine 
the potential effect of fish oil supplementation on EIB.  
 Pulmonary Function 
All participants performed pulmonary function tests at Weeks 0, 3, 6, and 8. PFTs 
were generally performed at least 4 hours after exercise and between the times of 10am 
and 8pm.  Eight weeks has been supported as a sufficient amount of time to see changes 
in pulmonary function measures in previous research (1).  Participants performed the 
spirometry (2001-2NP, EasyOne, Bohemia, NY) procedures in a seated position while 
breathing room air, with nasal breathing occluded by a nose clip. The procedure for all 
spirometry tests was 1) three normal tidal volume breaths, 2) maximal inhalation, 3) 
forced maximal exhalation, and 4) maximal inhalation.  This procedure required each 
participant to perform three acceptable spirograms.  If any pulmonary function 
measurement was technically unacceptable, the measurement was repeated.  FVC and 
FEV1 were collected at weeks 0, 3, 6, and 8.  Forced mid expiratory flow rate (FEF25-75%) 
and peak expiratory flow rate (PEF) were reported at weeks 0 and 8. 
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Exercise Challenge Test 
To elicit symptoms of EIB, a target ventilation (V̇E) was required. Due to the 
relationship between V̇E and V̇O2, a target V̇O2 was calculated to elicit the target V̇E. The 
target workload for each subject was calculated using the subject’s predicted V̇O2. Target 
workload was chosen in order to achieve ventilation between 50 and 60% of predicted 
maximum in the last 4 min of the exercise challenge test (2). Speed and grade were 
calculated using the ACSM treadmill running equation required to elicit the target V̇O2. 
The protocol used for the 8-minute treadmill exercise challenge test is below:   
Minute 1: 60 % of target V̇O2  
Minute 2: 70 % of V̇O2  
Minute 3: 90 % of V̇O2  
Minutes 4-8: 100 % of V̇O2  
Heart rate was monitored using a F1 Polar Heart Rate Monitor (Polar, Helsinki, Finland).  
A mouthpiece and nose clip were worn for the full duration of the test.  
Identification of EIB 
A subset of participants performed pulmonary function tests before and after an 
exercise challenge test at Weeks 0 and 8. Spirometry was assessed immediately before 
(baseline) and at 1, 5, 10, 15, and 20 following an exercise challenge test. The percent 
decline in FEV1 at each time point from the baseline value was calculated using the 
following equation: % decline = (highest pre-exercise challenge test FEV1 – lowest post-
exercise challenge test FEV1 at each time point)/ (highest pre-exercise challenge test 
FEV1). Participants who demonstrated a decrease in FEV1 greater than 10% were 
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identified as having EIB. The maximum percent decline in FEV1 was determined using 
the largest value obtained at Weeks 0 and 8.  
Supplementation 
 Participants with EIB (n=2) consumed 2g omega-3 fish oil (Ultimate Omega, 
Nordic Naturals, city state) two times daily, at breakfast and dinner. This dose of 4g per 
day has previously been shown to reduce inflammation in the respiratory system in elite 
and active participants (7).  Adherence to the treatment regimen was monitored by asking 
the participants to document the dose of capsules consumed daily and to return any 
unused capsules.  
Urinary Analysis of Bronchoconstrictive Mediators 
 Urine samples were collected before and 90 min after the exercise challenge test 
during laboratory visits at week 0 and week 8 in participants with EIB. Urine samples 
were immediately stored in a freezer (-18oC). Samples were transported to the laboratory 
using a cooler filled with ice and stored at -80oC until analysis. Urine concentrations of 
cysteinyl leukotrienes (LTC4-LTE4) were measured using enzyme linked immunosorbent 
assay (ELISA; Cayman Chemical, Ann Arbor, MI) in triplicate. All assay wells were 
washed with ultrapure water and a buffer.  An ELISA standard was added to particular 
cells and then the samples were added.  Once incubated overnight at 4oC, the assay was 
developed using a reagent. Assay wells were emptied and washed with a buffer 5 times 
before being filled with a reagent and incubated for 90 more minutes at room 
temperature.  The assay plate was read at a wavelength between 405 and 420 mm and the 
absorbance was checked at a range of 0.3-1.5 AU.  Cysteinyl leukotrienes and creatinine 
were analyzed using a database provided by Cayman Chemical. Cysteine leukotriene 
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values were normalized for urinary creatinine levels to minimize effect of excessive 
dilution in the urine (11).    
Statistical Analysis 
 Statistical Package for the Social Science (SPSS; Cary, NC) was used for analysis 
of data. One-way analyses of variance (ANOVA) were completed to determine the 
progression of pulmonary function (FVC, FEV1, and FEV1/FVC) over time.  Paired 
samples t-test was used to determine change in PEF, FEF25-75%. The lack of subjects 
precluded statistical analysis of change in leukotriene concentration at week 0 and week 
8.   Statistical significance was set at < 0.05. Data are expressed as mean ± standard 
deviation (SD).  
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Chapter 4 
RESULTS 
Topics discussed in this chapter include results regarding the following: (a) 
participant characteristics, (b) PFT results for participants without EIB, (c) PFT results 
for participants with EIB, (d) urinary analysis measures in EIB participants, (e) diet and 
bronchodilator usage, (f) average yardage per university, and (g) average pool chemical 
content per university.  
Participant Characteristics  
A total of thirteen participants (N=13; 12 females) consented to participate in the 
study. Anthropometric data for participants are displayed in Table 2. No participants 
reported any history of cardiovascular, respiratory, or metabolic diseases. All participants 
were never-smokers. Participants were involved in swimming training at the time of the 
investigation.  
Table 2. Pulmonary function and EIB participant characteristics (mean±SD). 
 Age (y) Height (cm) Weight (kg) BMI (kg∙m-2) 
Pulmonary 
Function (n=11) 
20.3±0.5 173.4±5.5 73.7±12.0 24.4±2.9 
EIB (N=2) 20.5±2.1 166.4±5.4 61.6±6.8 22.2±1.0 
 
Pulmonary Function  
 In participants without EIB (N=11), there were no significant changes in 
pulmonary function measures from week 0 to week 8. FVC as an absolute value and as a 
percent of predicted (24) at weeks 3, 6, and 8 were similar to that at study entry (Figures 
3 and 4).    
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Figure 3. Forced vital capacity (FVC) at weeks 0, 3, 6, and 8 of a competitive indoor swim season in 
participants without exercise-induced bronchoconstriction (mean±SD). 
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Figure 4. Forced vital capacity (FVC) as a percent of predicted at weeks 0, 3, 6, and 8 of a competitive 
indoor swim season in participants without exercise-induced bronchoconstriction (mean±SD). 
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FEV1 as an absolute value and as a percent of predicted (24) at weeks 3, 6, and 8 were 
similar to that at study entry (Figures 5 and 6). 
 
Figure 5. Forced expiratory volume in the first second (FEV1) from week 0 to week 8 of a competitive 
indoor swim season in participants without exercise-induced bronchoconstriction (mean±SD). 
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Figure 6. Forced expiratory volume in the first second (FEV1) as a percent of predicted at weeks 0, 3, 6 and 
8 of a competitive indoor swim season in participants without exercise-induced bronchoconstriction 
(mean±SD). 
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FVC % predicted, PEF, and FEF25-75% as absolute values at weeks 3, 6, and 8 were 
similar to that at study entry (Figure 7-9).  
 
Figure 7. Forced expiratory volume in the first second divided by forced vital capacity (FEV1/FVC) at 
weeks 0, 3, 6, and 8 of a competitive indoor swim season in participants without exercise-induced 
bronchoconstriction (mean±SD). 
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Figure 8.  Peak expiratory flow (PEF) for participants without EIB at weeks 0 and 8 (mean±SD). 
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Figure 9. Forced expiratory flow 25–75% (FEF25-75%) for participants without EIB at weeks 0 and 8 
(mean±SD). 
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Pulmonary Function of EIB Fish Oil Participants 
 Participants with EIB (n=2) exhibited a decrease in FEV1 greater than or equal to 
10% (Figure 10 and 11). Subject 1 experienced a 34.2% decrease in FEV1 at week 0 and 
a 19.5% decrease in FEV1 at week 8. Subject 2 experienced a 11.6% decrease in FEV1 at 
week 0 and a 11.9% decrease in FEV1 at week 8, 	
 
Figure 10. Change in forced expiratory volume in the first second (FEV1 ) from before to after the exercise 
challenge tests in Subject 1. 
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Figure 11. Change in forced expiratory volume in the first second (FEV1 ) from before to after the exercise 
challenge tests in Subject 2. 
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To the exercise challenge test was set to elicit 60% of the target  V̇O2 for the 1st minute, 
then 70%, 90%, and 100% for the 2nd, 3rd, and 4th through 8th minutes, respectively. 
Percent target V̇O2 reached by subjects 1 and 2 are displayed in Figure 12 and 13.  
	
 
Figure 12. Percent target V̇O2 reached during exercise challenge tests at week 0 and week 8 for Subject 1. 
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Figure 13. Percent target V̇O2 reached during exercise challenge tests at week 0 and week 8 for Subject 2. 
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Ventilation achieved at each minute during the exercise test for subjects 1 and 2 are 
displayed in Figure 14 and 15. Subject 1’s target Ve was 64.3 L/min at week 0 and 
60.3L/min at week 8. These values were achieved at both weeks. Subject 2’s target Ve 
was 61.8 L/min at week 0 and 59.6 L/min. These values were achieved at both weeks. 
 
Figure 14. Ventilation (Ve) reached during exercise challenge tests at week 0 and week 8 for Subject 1. 
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Figure 15. Ventilation (Ve) reached during exercise challenge tests at week 0 and week 8 for Subject 2. 
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FVC as an absolute value and as a percent of predicted (24) at weeks 3, 6, and 8 were 
similar to that at study entry. (Figure 16 and 17) 
	 
Figure 16. Forced vital capacity (FVC) at weeks 0, 3, 6, and 8 of a competitive indoor swim season in 
participants with exercise-induced bronchoconstriction. 
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Figure 17. Forced vital capacity (FVC) percent predicted at weeks 0, 3, 6, and 8 of a competitive indoor 
swim season in participants with exercise-induced bronchoconstriction. 
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FEV1 as an absolute value and as a percent of predicted (24) at weeks 3, 6, and 8 were 
similar to that at study entry. (Figure 18 and 19).  
 
Figure 18. Forced expiratory volume in the first second (FEV1)   changes from week 0 to week 8 of a 
competitive indoor swim season in participants with exercise-induced bronchoconstriction. 
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Figure 19. Forced expiratory volume in the first second (FEV1) percent predicted  at weeks 0, 3, 6, and 8 of 
a competitive indoor swim season in participants with exercise-induced bronchoconstriction. 
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FVC % predicted (24), PEF, and FEF25-75% as absolute values at weeks 3, 6, and 8 were 
similar to that at study entry (Figure 20-22).  
	 
Figure 20. Forced expiratory volume in the first second divided by forced vital capacity (FEV1/FVC) at 
weeks 0, 3, 6, and 8 of a competitive indoor swim season in participants with exercise-induced 
bronchoconstriction. 
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Figure 21. Peak expiratory flow (PEF) for participants with EIB at weeks 0 and 8. 
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Figure 22. Forced expiratory flow 25–75% (FEF25-75%) for participants with EIB at weeks 0 and 8. 
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Urinary Analysis Measures in EIB Participants 
 No relative differences or changes were found in leukotriene concentrations in the 
urine when normalized for creatinine (Figure 23). 
 
Figure 23. Leukotriene/Creatinine concentrations from week 0 to week 8. 
Diet and Bronchodilator Usage 
There were no abnormal amounts or change in amounts of omega-3 consumed from 
week 0 to week 8 by EIB participants as shown by the self-reported FFQ (Figure 24 and 
25). Data is expressed as 0 being no consumption (no consumption), 1 being low 
consumption (once a month), 2 being moderate consumption (once a week), and 3 being 
high consumption (more than twice a week).  Medication logs were issued at each visit. 
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No participants reported being prescribed an inhaler from the beginning to the end of the 
study.  
 
Figure 24. Food Frequency from week 0 to week 8 as reported by Subject 1. 
 
Figure 25. Food Frequency from week 0 to week 8 as reported by Subject 2. 
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Average Yardage  
Participants completed 7.1±1.7 swim practices per week during the study. 
Average pool exposure hours per week was 14.25±1 hours. Average yardage per practice 
was 5400±250 yards per day. Teams had two pool practices a day on Monday and 
Wednesdays resulting in a total of 4 hours of pool exposure of those days. 
Average Pool Chemical Content per University  
  Both pools used stabilized chlorine disinfectants.  Pools were chlorinated using 
calcium hypochlorite ±ts and manual chorine addition (15-gallon buckets). Pools were in 
line with recommended levels made by swimming pool and spa management guidelines 
for temperature and chlorine levels. Both pools maintained a temperature of 26.6 ºC over 
the course of 8 weeks. One location maintained a chlorine level of 1.4ppm and the other 
was at 2.0ppm.  The pH of both pools was 8 during all 8 weeks. The pH level for pools 
over the course of the 8-week study was higher than recommended.  
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Chapter 5 
DISCUSSION 
The purpose of this study was twofold: 1) to comprehensively examine whether or 
not spirometric indicators of pulmonary function change over an 8-week portion of the 
indoor swim season in competitive collegiate swimmers and 2) to perform a pilot 
investigation on the efficacy of fish-oil supplementation in swimmers with EIB over the 
course of 8 weeks. Contrary to our hypothesis, no significant changes were observed in 
FVC or FEV1 over the course of an 8-week indoor swim season.  Further, additional 
spirometric indicators (PEF, FEF) did not change over the course of the 8 weeks.  
Participants in this study were Division I and II college swimmers.  The study 
consistent of 12 females and 1 male 20±2 years of age.  Participants were specifically 
recruited due to their exposure to chloramines on the surface of the pool water during 
practice.  All participants were classified as competitive swimmers (47). The 8 weeks of 
data collection started at the beginning of the college indoor swim season. Researchers 
chose this time of year to collect data because participants were just coming back from 
summer break and it was the time that interfered the least amount with championship 
season. The beginning of the swim season allowed researchers to look at the change in 
airway function from the participants’ entrance into the pool environment after summer 
break.  
It is well known that swimmers have larger lung volumes when compared to other 
athletes and general population (12, 15, 57).  Pulmonary function measures of all 
participants were above the lower limits of normal at study entry with nearly all mean 
values reaching above 90% of predicted (24).  Vaccaro et al. found measures of TLC, 
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FVC, and FEV1 in child and preadolescent swimmers were approximately 10-16% above 
normal after 3 years of training (41, 57). When compared to land based activities 
(runners, basketball, canoeing, and rowing) and sedentary controls, swimmers had 
superior FEV1 independent of stature and age (12, 15).  
Nordberg et al. (46) reported a significant relationship between the number of 
hours spent in the swimming pool environment and the amount of acute symptoms 
associated with asthma and EIB (i.e. dyspnea, cough, nose irritation, throat irritation, eye 
irritation). Due to the volume of hours swimmers in this current study spent in this pool, 
it was expected to see a significant decrease in FEV1 over the course of a swim season. In 
the Nordberg et al. study, researchers reported a significant decrease in pool attendees 
(swimmers, lifeguards, etc.) FEV1 after two hours of exposure to the pool environment 
(46). Jacobs et al. reported considerable lung function changes and patterns were found in 
swimming pool instructors (29). 
The current investigation took place over 8 weeks of indoor swimming training. 
However, 8 weeks may not have been sufficient to observe significant changes in 
pulmonary function over time.  
Two different university teams were used as participant pools for this study.  Each 
team practiced at their specific institution throughout the eight weeks of the study.  Each 
team was followed their own training regimen during the course of the study. Yardage 
and pool time were also collected from coaches of both teams in this study, confirming 
training load.  Participants spent 14.25±1 hours per week in the swimming pool practices.  
The exposure to the swimming pool environment was greater than 2 hours on days 
participants doubled up on pool practices (Monday and Wednesday).  Swimmers 
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completed an average of 5400±250 yards of swimming per practice thus indicating a lack 
of exercise stimulus was not likely a factor in the lack of change in lung function of the 
participants.  The difference in training factors may be in part to why researchers saw no 
change in measures of pulmonary function over the course of 8 weeks.   
To investigate the presence and severity of EIB, conditions for provoking a 
response were provided. The exercise challenge protocol required the prediction of a 
target workload to achieve a target Ve and VO2  (2, 14). Though the EVH test is regarded 
as the gold standard, researchers saw subjects elicit symptoms of EIB, indicating this was 
an appropriate test to use (2).  EVH tests show a higher prevalence of EIB in individuals.  
The sample size used in the EIB pilot study was small. With the use of an EVH test it can 
be assumed use of this test could have led to an increase in total study participants in the 
EIB portion of this study.   
No relative differences in leukotriene concentration in the urine pre and post 
exercise challenge test were observed. Changes in leukotriene levels were not similar to 
other studies. Kumar et al. (32) found production of LTB4 in lung microsomes almost 
doubled after exhaustive exercise in the form of swimming.   Exhaustive swimming 
exercise in rats resulted in the enhanced production of LTB4 in lung microsomes. This 
led researchers to believe an increased number of leukotrienes would be found in the 
urine post exercise challenge test. However, researchers for this study found relatively no 
increase in the amount of leukotrienes in the urine post exercise challenge test. It is 
possible participant’s baseline values were not normalized when the pre-exercise test 
sample was taken.  Researcher has shown leukotriene concentration values return to 
baseline 3 to 7 hours after symptom evoking stimulus (i.e. exercise) (38). All participants 
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were asked to refrain from exercise at least 4 hours prior to giving a sample and 
participating in the study.  The body may not have fully returned to baseline after 4 hours 
before the collection causing discrepancy in data. 
Limitations 
 Sample size of the EIB pilot study did not allow for any statistical analysis. The 
absence of a metabolic cart hindered the researcher ability to perform an EVH test 
compared to an exercise challenge test. The inability to collect ventilation and 
trichloramine data from each location did not allow for a comparison between pool 
environments to be made.  
Future Directions 
It may be imperative to study coaches and/or lifeguards to determine if there 
detrimental effects to their pulmonary function as well. Futures studies on pool attendee 
pulmonary function can determine whether the air on the surface of the water or the pool 
environment causes more cases of acute asthma and EIB symptoms. 
Conclusion 
In conclusion, it is important to understand the physiological impact inhalation of 
chemical by-products may have on swimmers throughout their lifetime. Though no 
significant differences I pulmonary function over 8 weeks were found in this study, 
respiratory limitations in swimmers have been noted in other research.  Looking at the 
impact of the swimming pool environment on swimmers’ lung volumes and acute asthma 
symptoms may help to ultimately improve the swimmers performance over the course of 
his/her swimming career. A better understanding of treatments for asthma and EIB 
symptoms is needed to help abate long term respiratory limitations that may occur due to 
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pool environment exposure. It is also important to further exam pool quality standards to 
provide a safe and healthy pool environment for these athletes.  
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Appendix A: Informed Consent 
Appalachian State University 
Informed Consent for Participants in 
Research Projects Involving Human  
 
 
Title of Project: Pulmonary Function in Competitive Swimmers over an Indoor 
Swim Season 
 
IRB Study #: 17-0274 
  
Principal    
Investigator:  Hannah Snyder, M.S.  Email: snyderhe@appstate.edu 
     
Research Assistants: Jonathon Stickford, Ph.D. Email: stickfordjl@appstate.edu  
     
 
This is to certify that I,                                                                             have been given 
the following information with respect to my participation as a volunteer in a 
program of investigation under the supervision of Hannah Snyder, M.S. to which 
Jonathon Stickford, Ph.D. may be assisting. 
 
1. Purpose of the study: 
Repeated exposure to disinfectant by-products in swimming pool environments over 
an indoor swim season may contribute to poorer respiratory health in swimmers. Fish 
oil supplementation, however, may play a protective role in airway function.  
The purpose of this study is threefold: 1) to asses whether or not spirometric indicators 
of pulmonary function change over a swim season, 2) to assess if a decrease in FEV1  in 
swimmers with a decrease in FEV1 of greater than 10% worsen over the course of a 
swim season, and 3) to assess if  fish-oil supplementation abates the worsening of 
FEV1 in swimmers with a decrease greater than 10 percent over the course of a swim 
season. 
2. Inclusion Criteria: You may participate in the study if the following apply to you: 
 Sex: Male or Female 
 Ethnicity: Any 
 Age: 18-25 years 
 Without injury or illness that prevents them from practicing/competing 
 Interest in participating in a research study assessing pulmonary function and the 
effects of dietary supplementation on respiratory function 
 Understand written and oral instructions in English  
 Provides informed consent 
 Available during times the data collection is offered 
 All subjects must be nonsmokers 
 Must be a competitive swimmer 
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Exclusion Criteria: You should not participate in this study if any of the following 
apply to you: 
 Known cardiovascular, metabolic or renal disease, or signs/symptoms suggestive 
of cardiovascular, metabolic or renal disease will exclude you from participation. .  
 Current smoker.  
 
3. Procedures: Please read the descriptions of each experimental day and write your 
initials in the space provided.  
 
Table 1. Study procedures listed by visit number. 
Visit 1 Visit 2 Visit 3 Visit 4 
Informed Consent Pulmonary 
Function Test 
Pulmonary 
Function Test 
VO2submax Testing 
Medical History   Urine Sample 
Collection 
VO2submax Testing    
Urinary Sample 
Collection 
   
 
 
________ initial      Consent and Questionnaires: At this screening visit, the study will 
be explained in-depth to you by the PI or a trained research assistant. You will be provided 
time to consider your options and get all questions answered - if you agree to participate, 
you will then provide your written informed consent. 
 
________ initial      Pulmonary Function Testing (PFT): You will be asked to perform 
tests of breathing function. The protocol will follow that described by the American 
Thoracic Society. These tests include measurement of the total volume of air your lungs 
can hold, the volume of air that you can push out with one maximal breath, the volume of 
air that you can forcefully breathe out in one second, and the maximum voluntary volume 
of air that you can breathe in 12 seconds (MVV). For all these procedures, you will wear 
nose clips and breathe through a disposable mouthpiece. These procedures will take ~60 
minutes total. 
 
________ initial      Submaximal Aerobic Capacity Exercise Test (V̇O2submax): You will 
be asked to perform a submaximal exercise test to examine your cardiovascular fitness. 
This test will measure your submaximal exercise capacity and is often described as a 
V̇O2submax test. You should be rested, well nourished, and hydrated for the test and avoid 
caffeine and tobacco 3 hours before the test. Additionally, avoid alcohol 12 hours before 
the test. Report any medication that you are using to the testing staff before the test. When 
you are ready to perform the test, the investigators will help with necessary adjustments to 
testing equipment to assure your comfort. You will be fitted with a rubber mouthpiece and 
nose clip. Your breathing pattern, exercise metabolism, exhaled carbon dioxide, and 
	
	
64 
	
arterial blood oxygen level (via pulse oximetry) will be monitored during the test. This 
procedure will require ~40 minutes total, with exercise lasting approximately 8 minutes. 
 
 Treadmill Protocol 
 Exercise protocol for subject (should be 8 minutes of treadmill running): 
Minute 1: 60% of target VO2 (tVO2) (manipulate speed and grade) 
Minute 2: 70% of tVO2 (manipulate speed and grade) 
Minute 3: 90% of tVO2 (manipulate speed and grade) 
Minutes 4-8: 100% of tVO2 (manipulate speed and grade) 
* Target VO2 (tVO2) will be 40-60% of the predicted maximum voluntary 
ventilation (MVV, estimated as FEV1x35).  Target heart rate for stage 4 is 80-
90% of the subject's predicted maximum heart rate (Crapo et al., 2000). 
 
________ initial      Urine Sample Collection: A urine cup will be used to collect a small 
urine sample to measure your markers of inflammation approximately 5 minutes after the 
submaxVO2 test has ended.  
 
________ initial      Fish Oil and Placebo Supplementation: You will enter the study on  
your usual diet and receive either a fish oil or placebo (olive oil) supplement for the 
duration of the study (8 weeks). You will be randomly placed into the supplementation 
groups. The supplement compositions are displayed in Table 1. You will be asked to 
consume the supplement protocol daily.  
 
4.  Discomforts and risks: 
There are minimal risks involved with measuring/monitoring/performing: questionnaires, 
pulmonary function testing, flow-volume loops, and submaxVO2 tests. 
 
Submaximal Aerobic Capacity Exercise Test (VO2submax): VO2submax test risks include 
abnormal heart beats, abnormal blood pressure responses, muscle cramps, muscle strain 
and/or joint injury, delayed muscle soreness (1 to 2 days afterwards), light headedness, 
fatigue, and in rare instances, heart attack.  
 
Loss of Confidentiality: Any time information is collected; there is a potential risk for 
loss of confidentiality.  Every effort will be made to keep your information confidential; 
however, this cannot be guaranteed.  
 
Other Risks: There may possibly be other side effects that are unknown at this time. If 
you are concerned about other, unknown side effects, please discuss this with the 
researchers. 
 
Supplement Manufacturer Dosage 
Omega 3 Fatty Acid Nordic Naturals 4.0 g/day 
Placebo: Olive Oil 
Swanson Organic Extra 
Virgin Olive Oil 
4.0 g/day 
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How you can help reduce some of the risks:  During your participation in this research, 
the researchers will closely observe your testing to determine whether there are problems 
that need medical care.  It is your responsibility to do the following: 
•  Ask questions about anything you do not understand. 
•  Keep appointments. 
•  Follow the study researchers’ instructions. 
•  Let the researchers know if your telephone number changes. 
•  Tell the researchers before you take any new medication. 
•  Tell your regular doctor about your participation in this research. 
•  Talk to a family member or friend about your participation in this research. 
 
 
5.   a. Benefits to me: There exists the potential that respiratory health could be improved as 
a result of your involvement in the study. 
b. Potential benefits to society: The results could alter interventional approaches for 
improving respiratory health in competative swimmers.  
 
6.  Alternative procedures that could be utilized:  Not participating in the study. 
The procedures used in this study are frequently used in research and are the most 
appropriate methods to accomplish the goals of this research. 
 
6.  Time duration of the procedures and study:   
________ initial  Visit 1 (about 2 hours). 
________ initial  Visit 2 (about 1 hour). 
________ initial  Visit 3 (about 1 hour). 
________ initial  Visit 4 (about 2 hours). 
 
Approximately 6 hours Total 
 
7.  Statement of confidentiality: Volunteers are coded by an identification number for 
statistical analyses. All records are kept in a secure location. All records associated with 
your participation in the study will be subject to the university confidentiality standards 
and in the event of any publication resulting from the research no personally identifiable 
information will be disclosed.  
 
8.  Right to ask questions: Please contact Hannah Snyder, B.S. (919-368-4735), with 
questions, complaints, or concerns about this research. If you have any questions about 
your rights as a research subject, please contact the IRB Administrator at the Appalachian 
State University Institutional Review Board Office at (828) 262-2692, irb@appstate.edu.  
This study has been approved on August 30, 2017 by the Institutional Review Board 
(IRB) at Appalachian State University.  This approval will expire on August 30, 2018 
unless the IRB renews the approval of this research. 
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9.  Compensation: You will receive no monetary compensation for your participation in 
this study. 
 
10.  Injury Clause: In the unlikely event you become injured as a result of your 
participation in this study, standard emergency procedures will be followed. If you get 
hurt or sick when you are not at the research site, you should call your doctor or call 911 
in an emergency. If your illness or injury could be related to the research, tell the doctors 
or emergency room staff about the research study, the name of the Principal Investigator, 
and provide a copy of this consent form if possible. Please call the PI as soon as possible 
(Hannah Snyder, B.S. 919-368-4735). You will be responsible for any costs for medical 
care not paid by your insurance company. No other compensation is offered by 
Appalachian State University.  By signing this document, you are not waiving any legal 
rights that you have against Appalachian State University for injury resulting from 
negligence of the University or its investigators. 
 
11.  Voluntary participation: Your participation in this study is voluntary. You may 
withdraw from this study at any time by informing the research personnel. You may decline 
to answer certain questions and may decide not to comply with certain procedures. 
However, your being in the study may be contingent upon answering these questions or 
complying with the procedures. The researcher may end your role in the study without your 
consent if the researcher deems that your health or behavior adversely affects the study or 
increases risks to you beyond those approved by the Institutional Review Board and agreed 
upon by you in this document. You have been given an opportunity to ask any questions 
you may have, and all such questions or inquiries have been answered to your satisfaction. 
 
You must be 18 years of age or older to take part in this research study. If you agree to 
take part in this research study and have read the information outlined above, please 
sign your name and indicate the date below.  You will be given a copy of this signed 
and dated consent form for your records. 
 
 
______________________________________________ 
Volunteer      Date 
 
I, the undersigned, have defined and explained the studies involved to the above 
volunteer. 
 
______________________________________________ 
Person Obtaining Consent   Date 
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Appendix B: Script for Class Recruitment 
Script for Class Recruitment 
 
Hello! Researchers in the Department of Health and Exercise Science at Appalachian 
State University are interested in to assessing pulmonary function and markers of 
bronchoconstriction over the course of an indoor season in competitive swimmers.  We 
are also interested in examining the potential influence of fish oil supplementation on 
pulmonary function and markers of bronchoconstriction in competitive swimmers over 
the course of an indoor season.  
We are looking for competitive swimmers aged 18-25 years to participate in a study.  
The study will require four visits (or about 6 hours in total).  At the first visit, you will 
complete some questionnaires and we will measure your lung function. During the 
remaining visits, you will perform pulmonary function tests to assess potential changes 
throughout the season.  
To be eligible, you must be healthy, non-smoking, able to participate in practice and 
meets throughout the swim season. You must not have any cardiovascular, metabolic, or 
renal disease.  
If you are interested, please contact Hannah Snyder at snyderhe@appstate.edu or 
919.368.4735.  
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Appendix C: Script for Email Recruitment 
 
To whomever it may concern. 
 
The researchers at Appalachian State are conducting a study on competitive swimmers.  
The purpose of this study is threefold: 1) to asses whether or not spirometric indicators of 
pulmonary function change over a swim season, 2) to assess if a decrease in FEV1  in 
swimmers with a decrease in FEV1 of greater than 10% worsen over the course of a swim 
season, and 3) to assess if  fish-oil supplementation abates the worsening of FEV1 in 
swimmers with a decrease greater than 10 percent over the course of a swim season. 
 
The visits and tests are: 
  
Visit 1: 
 Consent & HIPAA – review and sign  
 Review of Medical History  
 Lung Function Tests  
 Submax Aerobic Capacity Test 
 Urine Collection 
 Time commitment:  2 hrs 
  
Visit 2: 
 Lung Function Tests 
 Time commitment: .5 hr 
  
Visit 3: 
 Lung Function Tests 
 Time commitment: .5 hr 
  
Visit 4 
 Lung Function Tests  
 Submax Aerobic Capacity Test 
 Urine Collection 
 Time commitment:  2 hrs 
  
If you are only participating in this study to evaluate the change in pulmonary function 
over the course of eight weeks and did not have a fall in FEV1 greater than 10%, you will 
NOT participate in the Submaximal Aerobic Capacity Exercise Test. 
 
For your safety, we will monitor your heart rate response to during all exercise tests. Please 
let me know if you have any questions or would like additional information. If you are 
interested in participating tin the study, please contact me to arrange a time to visit the 
laboratory. 
 
Hannah Snyder, B.S. 
snyderhe@appstate.edu; 919-368-4735 
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Appendix D: Medication Log 
Medication Log 
Medication Dosage Date Taken 
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Appendix E: Food Frequency Questionnaire 
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Appendix F: 24-Hour Health History Form 
 
  
	
	
73 
	
Vita 
	
Hannah Elizabeth Snyder was born in Fort Collins Colorado, to Douglas and 
Juanita Snyder, She graduated Magna Cum Laude with Honors from Towson University 
in Maryland in May 2016 to study Exercise Science and was awarded a Bachelor’s of 
Science degree.  She was a three time Academic All-American as a Division I swimmer. 
In the fall of 2016, she entered Appalachian State University began study toward a 
Master of Sciences degree in Exercise Science.  The M.A. was awarded in May of 2018. 
Hannah remains active in the swimming community and wishes to pursue a career in the 
field.   
 
